Journal “should have revealed scientist's connection to company”BMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7329.70 (Published 12 January 2002) Cite this as: BMJ 2002;324:70
- Charles Marwick
A transatlantic fracas involving alleged conflict of interest is brewing between a Dutch scientist and an American scientist over an editorial on the safety of third generation oral contraceptives that appeared in the New England Journal of Medicine on 20 December (2001;345:1841-2).
The scientist in the Netherlands is Dr Jan Vandenbroucke of the department of epidemiology at the Leiden University Medical Centre. The American scientist is Dr Meir Stampfer of the Harvard School of Public Health, Boston.
Dr Vandenbroucke takes issue with the conclusions of the editorial, which commented on a study of the risk of myocardial infarction among women taking oral contraceptives, published in the same issue of the journal. The editorial, by Dr Stampfer and his coauthor, Dr Lisa Chasan-Taber of the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial